injections tirzepatide What Is Tirzepatide? How It Works & What to Expect Exploring Tirzepatide: A Revolutionary Approach

~15% average weight loss Common side effects: nausea, constipation, diarrhea Also shown to reduce cardiovascular and kidney disease risks in some patients Tirzepatide (Zepbound) A dual-action medication: GLP-1 + GIP Enhances insulin, appetite control, and fat metabolism Average weight loss: ~20% in clinical trials Weekly injection Similar GI side effects to semaglutide Retatrutide (Coming Soon) A triple-agonist: GLP-1 + GIP + glucagon receptor Early studies show weight loss approaching 25% Still in clinical trials

Recent studies have provided valuable insights into how each medication performs in clinical trials

REST regulation of gene networks in adult neural stem cells

and LifeMD wasn't on the list

The link between obesity and cancer It is well established that obesity is associated with at least 13 types of cancer, including breast (post-menopausal), colorectal, endometrial, kidney, pancreatic, and esophageal cancers